GR3002249T3 - Benzothiazepine vasodilators having aralkyl substitution - Google Patents

Benzothiazepine vasodilators having aralkyl substitution

Info

Publication number
GR3002249T3
GR3002249T3 GR91400829T GR910400829T GR3002249T3 GR 3002249 T3 GR3002249 T3 GR 3002249T3 GR 91400829 T GR91400829 T GR 91400829T GR 910400829 T GR910400829 T GR 910400829T GR 3002249 T3 GR3002249 T3 GR 3002249T3
Authority
GR
Greece
Prior art keywords
vasodilators
benzothiazepine
aralkyl substitution
aralkyl
substitution
Prior art date
Application number
GR91400829T
Other languages
English (en)
Inventor
John Robert Carson
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of GR3002249T3 publication Critical patent/GR3002249T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR91400829T 1986-08-20 1991-07-04 Benzothiazepine vasodilators having aralkyl substitution GR3002249T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89829886A 1986-08-20 1986-08-20

Publications (1)

Publication Number Publication Date
GR3002249T3 true GR3002249T3 (en) 1992-12-30

Family

ID=25409243

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400829T GR3002249T3 (en) 1986-08-20 1991-07-04 Benzothiazepine vasodilators having aralkyl substitution

Country Status (6)

Country Link
EP (1) EP0256888B1 (el)
JP (1) JP2622385B2 (el)
AT (1) ATE64925T1 (el)
DE (1) DE3771143D1 (el)
ES (1) ES2038668T3 (el)
GR (1) GR3002249T3 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624117B1 (fr) * 1987-12-08 1991-02-22 Synthelabo Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2630109B1 (fr) * 1988-04-19 1991-11-29 Synthelabo Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
FR2638745B1 (fr) * 1988-11-08 1994-01-14 Synthelabo Derives de ((n-alkylthioalkyl-methylamino)-2 ethyl)-5 benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2641536B1 (fr) * 1989-01-11 1991-03-15 Synthelabo Derives d'alcanoyloxy-3 ((n-(aryl-2 oxo-2 ethyl) methylamino)-2 ethyl)-5 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
US4952692A (en) * 1989-04-04 1990-08-28 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
FR2670785B1 (fr) * 1990-12-20 1993-07-09 Synthelabo Derives de (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique.
FR2672601B1 (fr) * 1991-02-08 1994-10-14 Synthelabo Derives de benzo-1,5-thiazepine, leur preparation et leur application en therapeutique.
WO2005035505A2 (en) * 2003-09-30 2005-04-21 Artesian Therapeutics, Inc. Compounds with phosphodiesterase inhibiting and calcium channel blocking activities

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives

Also Published As

Publication number Publication date
JPS63119478A (ja) 1988-05-24
ATE64925T1 (de) 1991-07-15
JP2622385B2 (ja) 1997-06-18
DE3771143D1 (de) 1991-08-08
EP0256888A1 (en) 1988-02-24
EP0256888B1 (en) 1991-07-03
ES2038668T3 (es) 1993-08-01

Similar Documents

Publication Publication Date Title
TW269678B (el)
PH30007A (en) 7-(Substituted)-9-¬(sub-stituted glycyl)amido¾-6-dimethyl-6-deoxytetra-cyclines
IL99952A0 (en) Retroviral protease inhibiting compounds
AU3043592A (en) Triazolopyrimidine derivatives
EP0562049A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
EP0171887A3 (en) Anti-diabetic compounds
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
GR3002249T3 (en) Benzothiazepine vasodilators having aralkyl substitution
GR3023457T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
ZA883444B (el)
EP0171886A3 (en) Anti-diabetic compounds
ZA94748B (en) Cytotoxic and antiviral compound.
HU906010D0 (en) New substituted alkyl-piperidine derivatives
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
AU563990B2 (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives
AU7527387A (en) 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties
EP0551844A3 (el)
AU568967B2 (en) 2-alkoxycarbonyl alkyl-3-oxo-5,6-diaryl-1,2,4-triazines
EP0381114A3 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
NZ234924A (en) 1,3-oxazine derivatives and antitussive compositions
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
AU7637591A (en) Cis and trans stilbenes and their compositions for the treatment of hypertension